Utilizing multiple technology platforms, LakePharma offers a range of services and solutions to identify novel monoclonal antibodies and determine their sequences.
1. Hybridoma technology: comprehensive, customized hybridoma campaigns for therapeutic antibody discovery.
2. Naïve synthetic, or immune antibody libraries: LakePharma has licensed multiple phage (XOMA, Moradec, etc.) and yeast antibody display libraries, and employs them for unparalleled de novo antibody discovery to be used as therapeutics or diagnostics (reagents).
Please contact LakePharma at email@example.com for custom quotes and details.